Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,256,320
-$1,405,248 QoQ
Shares Held
1,349,072
-3.5% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Derivatives in VNDA
reported options exposure · as of Jun 30, 2020CallValue
$0
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. VNDA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in VNDA
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,256,320 | 1,349,072 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,661,568 | 1,398,201 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,634,691 | 978,990 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,304,901 | 662,305 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,486,807 | 526,866 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $806,150 | 175,632 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $955,413 | 199,460 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $480,457 | 102,443 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $484,594 | 85,769 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,187,670 | 532,280 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,304,276 | 783,004 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,607,344 | 603,552 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,409,263 | 669,084 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,451,058 | 508,256 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,298,681 | 446,371 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,522,457 | 356,524 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,462,111 | 409,368 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,428,434 | 303,133 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,197,453 | 331,259 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,095,279 | 122,245 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,245,019 | 243,841 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 ALXN | — | 57,783 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $2,712,416 | 180,587 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 ALXN | — | 16,604 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $634,096 | 48,257 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 9,336 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 ALXN | — | 2,000 | Call | Sole | 2020-08-14 | |
| 2020-06-30 ALXN | — | 59,821 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $1,201,234 | 105,003 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 ALXN | — | 29,700 | Put | Sole | 2020-05-15 | |
| 2020-03-31 ALXN | — | 356,892 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 ALXN | — | 37,600 | Call | Sole | 2020-05-15 | |
| 2020-03-31 | $1,734,377 | 167,411 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||